Health-related quality of life with nalirifox versus nabpaclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): EORTC QLQ-C30 results from the NAPOLI 3 trial Meeting Abstract
| Authors: | Melisi, D.; Macarulla, T.; de la Fouchardiere, C.; Cid, R. A. P.; Chandana, S.; Dean, A.; Kiss, I.; Lee, W.; Goetze, T. O.; Van Cutsem, E.; Paulson, A. S.; Bekaii-Saab, T.; Pant, S.; Hubner, R.; Xiao, Z.; Zhang, L.; Benzaghou, F. M.; O'Reilly, E. M.; Wainberg, Z. A. |
| Abstract Title: | Health-related quality of life with nalirifox versus nabpaclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): EORTC QLQ-C30 results from the NAPOLI 3 trial |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S896 |
| End Page: | S897 |
| Language: | English |
| ACCESSION: | WOS:001087480202292 |
| DOI: | 10.1016/j.annonc.2023.09.2568 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1619P -- Source: Wos |
